- About Us
- Services & Solutions
- Services by Functionality
- Services by Development Stage
- Proprietary Technologies
- Specialized Expertise
- Quality & Compliance
- Insights & Resources
- News & Events
At MedPharm, we offer a complete suite of services designed to accelerate development, reduce risk, and ensure commercial success for topical and transdermal drug products. Built on a foundation of scientific rigor, regulatory excellence, and decades of proven expertise, our services guide your product from concept through to commercialization.
With global facilities, proprietary technologies, and a collaborative approach, MedPharm delivers unmatched expertise across a comprehensive range of services to support your product development.
Explore our services by function below to see how we support your development journey.
Our analytical and bioanalytical capabilities support every stage of product development. From method development and validation to QC and stability testing, we ensure your data is accurate, reproducible, and fully compliant with global regulatory standards.
We produce high-quality clinical trial materials with speed, scalability, and precision. Our UK and US facilities are equipped for ICH stability testing, IND/IMPD-ready documentation, and reliable supply of Phase I–III materials with built-in flexibility to adapt to program changes.
GMP-Accredited and Market-Ready. MedPharm’s commercial facilities are purpose-built for semi-solids and liquids, including hormone and HPAPI formulations. With batch sizes ranging from 30L to 1500L, our end-to-end services cover compounding, filling, packaging, serialization, and quality release.
We develop innovative, phase-appropriate formulations aligned to your target product profile. Whether for new chemical entities, generics, or over-the-counter solutions, our scientists leverage deep excipient expertise and advanced in vitro models to design formulations that perform.
Our process development team ensures smooth tech transfer by establishing robust, scalable, and reproducible processes. We apply Quality by Design (QbD) principles, Design of Experiment (DoE) methodologies, and in-silico assessments to optimize processing variables early and efficiently.
Proprietary Technologies & Unique Models. Tap into MedPharm’s proprietary innovations like MedSpray®, MedFlux-HT®, ChubTur®, and disease-specific models for nail, mucosal, and ophthalmic applications. These specialty capabilities are designed to solve complex delivery challenges and accelerate approval timelines.
We offer an extensive portfolio of in vitro and ex vivo testing services—including IVRT, IVPT, MedFlux-HT®, and disease-specific models—to evaluate permeation, penetration, and performance. Our models are proven to de-risk development and support regulatory submissions worldwide.
Consultancy, Risk Mitigation & Regulatory Support. MedPharm offers a strategic layer of support through expert consultancy, GAP assessments, risk analysis, and regulatory guidance. Our team helps you identify vulnerabilities, build data-driven strategies, and confidently navigate regulatory interactions with the FDA, EMA, and MHRA.
